Medpace Holdings, Inc.
MEDP Healthcare Diagnostics & Research
Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.
- Revenue
- +8.50%
- EPS
- +24.6%
- Free cash flow
- −16.6%
Quarter to September 2026, against a year earlier
Follow MEDP
Alert me
Medpace Holdings, Inc. (MEDP) Operating margin
Medpace Holdings, Inc.'s operating margin over the twelve months to 30 September 2026 was 21.4%, up 0.2 percentage points from fiscal 2025 (21.1%). Over the past ten years it has ranged from 5.73% (fiscal 2015) to 21.2% (fiscal 2024); the current reading is higher than 91% of that period. That is above the Diagnostics & Research industry median of −5.68% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 21.1% | (0.05) |
| FY2024 | 21.2% | 3.33 |
| FY2023 | 17.9% | (1.23) |
| FY2022 | 19.1% | 1.70 |
| FY2021 | 17.4% | (0.65) |
| FY2020 | 18.0% | 3.26 |
| FY2019 | 14.8% | 0.44 |
| FY2018 | 14.3% | (0.53) |
| FY2017 | 14.9% | 2.42 |
| FY2016 | 12.5% | 6.72 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 23.1% | 2.36 |
| Jun 2026 | 20.8% | 0.73 |
| Mar 2026 | 20.0% | (1.60) |
| Dec 2025 | 21.6% | 0.14 |
| 40 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| MEDP Medpace Holdings, Inc. | 21.4% |
| QGEN QIAGEN N.V. compare | 21.2% |
| ILMN Illumina, Inc. compare | 21.2% |
| DGX Quest Diagnostics Incorporated compare | 14.6% |
| RVTY Revvity Inc. compare | 12.7% |
| LH Labcorp Holdings Inc. compare | 10.3% |
| ICLR ICON PLC compare | 8.72% |
| CRL Charles River Laboratories International, Inc. compare | 4.00% |
| GH Guardant Health, Inc. compare | −39.4% |
| Diagnostics & Research industry median | −5.68% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on MEDP
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement